tiprankstipranks
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market

iTeos Therapeutics (ITOS) Income Statement

Compare
182 Followers

iTeos Therapeutics Income Statement

Last quarter (Q3 2024), iTeos Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, iTeos Therapeutics's net income was $-45.36M. See iTeos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 12.60M$ 267.63M$ 344.77M$ 0.00$ 0.00
Gross Profit
$ 11.70M$ 266.82M$ 344.16M$ -535.00K$ -611.00K
Operating Expenses
$ 163.70M$ 138.04M$ 89.69M$ 39.31M$ 23.27M
Depreciation and Amortization
$ 898.00K$ 813.00K$ 615.00K$ 535.00K$ 611.00K
EBITDA
$ -151.10M$ 148.38M$ 257.08M$ -37.84M$ -21.72M
Operating Income
$ -151.10M$ 126.32M$ 244.90M$ -45.24M$ -28.05M
Other Income/Expenses
$ 42.07M$ 22.41M$ 11.56M$ 7.15M$ 5.71M
Pretax Income
$ -109.03M$ 148.74M$ 256.46M$ -38.09M$ -22.34M
Net Income
$ -112.64M$ 96.65M$ 214.52M$ -38.03M$ -22.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.15$ 2.72$ 6.10$ -1.09$ -0.64
Diluted EPS
$ -3.15$ 2.56$ 5.68$ -1.09$ -0.64
Weighted Average Shares Outstanding
35.76M 35.55M 35.18M 35.04M 35.02M
Weighted Average Shares Outstanding (Diluted)
35.76M 37.77M 37.77M 35.04M 35.02M
Currency in USD

iTeos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis